课题基金 / 基金详情

Lymphoma Defined Cytogenetically for Epidemiologic Study

Lymphoma Defined Cytogenetically for Epidemiologic Study
淋巴瘤的细胞遗传学定义用于流行病学研究
批准号:
7576747
负责人:
BRIAN C-H CHIU
金额:
$21.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2012-02-29

项目摘要

项目成果

BRIAN C-H CHIU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):非霍奇金淋巴瘤(NHL)的分析流行病学研究重点关注根据NHL亚型的危险因素是很重要的,因为:1)NHL包括异质性的恶性肿瘤,其病因各不相同;2)不同亚型的NHL发病率变化模式不同。目前,NHL不能再细分为流行病学研究的标准病理类别。我们建议根据BCL2、BCL6和C-MYC基因的重排来定义NHL,因为细胞遗传学研究表明,导致这些基因失调的复发性染色体异常在某些NHL亚型的发病机制中很重要。核心的创新假设是,由遗传异常定义的NHL离散亚群的危险因素不同,其基本原理是,具有特异性、非随机染色体异常的病例在病因学上可能比整体的NHL病例更密切相关。具体目的是调查BCL2重排阳性NHL、BCL6重排阳性NHL和C-MYC重排阳性NHL与吸烟、农业和农药暴露、造血癌家族史和动物脂肪饮食摄入的相关性是否不同。我们估计在内布拉斯加州进行的两项基于人群的病例对照研究中将有540个肿瘤块(其中530个将产生染色体信息)来自NHL病例,并将有1967个对照的数据进行比较。荧光原位杂交(FISH)技术将用于确定BCL2、BCL6和C-MYC基因的重排。NHL的亚型将根据是否存在特定的遗传异常来定义。逻辑回归模型将用于计算与暴露相关的NHL重新排列定义子集的优势比。多元逻辑回归将用于比较由重排定义的NHL离散子集之间的关联。这一结果将具有重要意义,因为它们可以为淋巴瘤发生的病因提供新的见解。由于研究人群具有良好的特征,并且已经收集了大量的暴露数据,因此目前的建议对于解决NHL(美国最常见的恶性肿瘤之一)的病因来说是极具成本效益的。长期目标是增进对疾病过程的了解,最终可能导致在一般人群中采取适当的预防措施。
英文摘要
DESCRIPTION (provided by applicant): It is important that analytic epidemiologic studies of non-Hodgkin's lymphoma (NHL) focus on risk factors according to NHL subtypes because: 1) NHL comprises a heterogeneous group of malignancies that vary in etiology; and 2) the patterns of change in NHL incidence vary across different subtypes. At this time, NHL cannot be subdivided into standard pathologic categories for epidemiologic studies. We propose to define NHL according to rearrangements of the BCL2, BCL6, and C-MYC genes because cytogenetic studies have shown that recurring chromosomal abnormalities leading to the deregulation of these genes are important in the pathogenesis of certain NHL subtypes. The central innovative hypothesis is that risk factors differ for discrete subsets of NHL defined by genetic abnormalities, The rationale is that cases with specific, nonrandom chromosomal abnormalities may be more closely related etiologically than NHL cases as a whole. The specific aims are to investigate whether the associations with cigarette smoking, farming and pesticide exposure, family history of hematopoietic cancer, and dietary intake of animal fat differs for BCL2 rearrangement-positive NHL, BCL6 rearrangement-positive NHL and C-MYC rearrangement-positive NHL. We estimate that 540 tumor blocks will be available (and of which, 530 will yield chromosomal information) from NHL cases in two existing population-based, case-control studies conducted in Nebraska, and there will be data on 1967 controls for comparison. Fluorescence in-situ hybridization (FISH) technique will be used to determine the rearrangements of the BCL2, BCL6, and C-MYC genes. Subtypes of NHL will be defined by the presence or absence of the specific genetic abnormalities. Logistic regression model will be used to calculate the odds ratios for rearrangement defined subsets of NHL associated with exposures. Polytomous logistic regression will be used to compare associations across discrete subsets of NHL defined by rearrangements. The results will be significant because they could provide new insights about the etiology of lymphomagenesis. Because the study population is well-characterized and extensive data on exposures have been collected, the current proposal is extremely cost-effective to address the etiology of NHL, one of the most common malignancies in this country. The long-term objective is to improve understanding of the disease process which may ultimately lead to appropriate preventive measures in the general population.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
  • 批准号:
    10912191
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2023
  • 负责人:
    BRIAN C-H CHIU
  • 依托单位:
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma
  • 批准号:
    10651370
  • 项目类别:
  • 资助金额:
    $69.17万
  • 财政年份:
    2023
  • 负责人:
    BRIAN C-H CHIU
  • 依托单位:
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research
  • 批准号:
    10640969
  • 项目类别:
  • 资助金额:
    $38.99万
  • 财政年份:
    2022
  • 负责人:
    BRIAN C-H CHIU
  • 依托单位:
A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research
  • 批准号:
    10413620
  • 项目类别:
  • 资助金额:
    $42.12万
  • 财政年份:
    2022
  • 负责人:
    BRIAN C-H CHIU
  • 依托单位:
海外基金